Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05258981 · ClinicalTrials.gov registry record · NA
The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults
A NA study of Congenital Heart Disease, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT05258981: Recruiting NA study of Congenital Heart Disease, sponsored by Boston Children's Hospital.
NCT05258981 is a NA study of Congenital Heart Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 225 participants, below the 470-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05258981, a NA study of Congenital Heart Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this proposal is to perform novel MRI analyses to determine the brain organizational changes associated with altered executive function and the modulating role of variants in neuroresilience and hypoxia response genes in adults with d-transposition of the great arteries (d-TGA).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT05258981 shows while recruiting
NCT05258981 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 470-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT05258981 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05258981 about?
NCT05258981 is a clinical study titled "The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults". The main purpose of this proposal is to perform novel MRI analyses to determine the brain organizational changes associated with altered executive function and the modulating role of variants in neuroresilience and hypoxia response genes in adults with d-transposition of the great arteries (d-TGA).
What is the current status of trial NCT05258981?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2022-07-01. Estimated completion is 2026-06.
What conditions does trial NCT05258981 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT05258981?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05258981?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05258981 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05258981's enrollment target sits among peer trials
225 15th of 63 higher than 49 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI